The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for etranacogene dezaparvovec (CSL Behring Australia Pty Ltd)
Active ingredients
etranacogene dezaparvovec
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
For the treatment of haemophilia B
Therapeutic area
Haematology